Quantitative results suggested that the concentration of 1-MT in melanoma 1 day after treatment with the microneedle system was 3-fold higher compared with free 1-MT treatment, and more anti-PD-L1 antibody was captured in tumor cells by immunofluorescence staining. The gene discussed is CD274; the disease is neoplasm.